Entera Bio Ltd.
ENTX
$1.99
$0.010.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 191.23% | -- | -- | 607.14% | 159.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 191.23% | -- | -- | 607.14% | 159.09% |
| Cost of Revenue | 245.83% | -- | -- | 1,025.00% | 242.86% |
| Gross Profit | -100.00% | -- | -- | 50.00% | 12.50% |
| SG&A Expenses | 19.29% | 16.69% | 15.01% | -12.79% | -27.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | 82.46% | 56.86% |
| Total Operating Expenses | 24.58% | 17.94% | 9.84% | -11.05% | -21.19% |
| Operating Income | -23.47% | -15.39% | -7.81% | 11.88% | 21.55% |
| Income Before Tax | -24.46% | -16.00% | -7.53% | 7.72% | 18.74% |
| Income Tax Expenses | -51.72% | -51.72% | -51.72% | 100.00% | -80.41% |
| Earnings from Continuing Operations | -24.20% | -15.78% | -7.33% | 7.56% | 19.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.20% | -15.78% | -7.33% | 7.56% | 19.60% |
| EBIT | -23.47% | -15.39% | -7.81% | 11.88% | 21.55% |
| EBITDA | -23.78% | -15.65% | -7.97% | 11.84% | 21.58% |
| EPS Basic | 2.36% | 9.80% | 17.41% | 24.43% | 28.71% |
| Normalized Basic EPS | 2.08% | 9.56% | 17.23% | 27.91% | 31.01% |
| EPS Diluted | 2.36% | 9.80% | 17.41% | 24.43% | 29.38% |
| Normalized Diluted EPS | 2.08% | 9.56% | 17.23% | 27.91% | 31.01% |
| Average Basic Shares Outstanding | 26.27% | 26.84% | 29.78% | 22.40% | 14.74% |
| Average Diluted Shares Outstanding | 26.27% | 26.84% | 29.78% | 22.40% | 14.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |